BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center for RNA Biomedicine - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://rna.umich.edu
X-WR-CALDESC:Events for Center for RNA Biomedicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Detroit
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Detroit:20260601T160000
DTEND;TZID=America/Detroit:20260601T170000
DTSTAMP:20260428T221257
CREATED:20260424T215324Z
LAST-MODIFIED:20260427T143402Z
UID:18600-1780329600-1780333200@rna.umich.edu
SUMMARY:Sarah Herridge\, Ph.D.\, BioNTech Australia - Special Lecture
DESCRIPTION:The Center for RNA Biomedicine presents Sarah Herridge\, Ph.D.\, Director\, Research and Scientific Affairs\, BioNTech Australia\n \nOn Monday\, June 1\, the Center for RNA Biomedicine will host RNA biology and RNA drug development expert Sarah Herridge\, Ph.D.\, for a special lecture titled\, “TDB (see abstract below).” \nSchedule — Monday\, June 1 | 4 p.m. – 5 p.m.\n4:00 p.m – 5:00 p.m. | Sarah Herridge\, Ph.D. Lecture — North Lecture Hall (Room 3695) Medical Science Building II \nAbstract and Speaker Info\nAbstract:\nTBD \nAbout Sarah Herridge\, Ph.D.:\nDr. Sarah Herridge is an accomplished leader with over 15 years of experience in RNA therapeutics development for oncology\, spanning the full spectrum from target discovery to clinical trials. She earned her PhD in Biochemistry in Germany and completed her postdoctoral training at Cold Spring Harbor Laboratory\, where she collaborated with Ionis Pharmaceuticals on pioneering RNA-based cancer therapies. Sarah has held leadership positions in academia\, including as Lab Head at the University of Otago in New Zealand\, and served as the Founder and Chief Scientific Officer for two startups in the RNA therapeutics sector: Amaroq Therapeutics and Fold AI. \nShe currently serves as Director of Research & Scientific Affairs at BioNTech in Australia. In her current role\, Sarah leads the development and execution of research strategy\, manages scientific collaborations and external partnerships\, oversees the onboarding of new research projects\, and drives the implementation of scientific engagement initiatives to advance BioNTech’s mission globally. \n 
URL:https://rna.umich.edu/events/sarah-herridge-ph-d-special-lecture/
LOCATION:Medical Science Building II\, 1137 Catherine St\, Ann Arbor\, MI\, 48109\, United States
END:VEVENT
END:VCALENDAR